Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Multicentre, Investigator-Blind, Parallel-Group Trial to Evaluate the Efficacy and Safety of MC2-01 Cream Compared to Vehicle and Active Comparator in Subjects With Mild-to-Moderate Psoriasis Vulgaris

NCT03308799 is registered in ClinicalTrials.gov with MC2 Therapeutics as lead sponsor.

NCT NCT03308799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03308799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Multicentre, Investigator-Blind, Parallel-Group Trial to Evaluate the Efficacy and Safety of MC2-01 Cream Compared to Vehicle and Active Comparator in Subjects With Mild-to-Moderate Psoriasis Vulgaris
Lead sponsor
MC2 Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
October 3, 2017
Completion date
June 8, 2018
Enrollment
794 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris